Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Hepatocellular × CTLA-4 Antigen × 30 days × Clear all

Sponsor

Conditions

Melanoma 5 Carcinoma, Renal Cell 4 Urinary Bladder Neoplasms 3 Urethral Neoplasms 3 Neoplasm Metastasis 3 Urogenital Neoplasms 2 Ureteral Neoplasms 2 Prostatic Neoplasms 2 Penile Neoplasms 2 Lung Neoplasms 2 Carcinoma, Transitional Cell 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Endometrioid 2 Carcinoma, Basal Cell 2 Vulvar Neoplasms 1 Urachal adenocarcinoma 1 Thyroid Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Somatostatinoma 1 Small Cell Lung Carcinoma 1 Seminoma 1 Rectal Neoplasms 1 Rare Diseases 1 Pseudomyxoma Peritonei 1 Pheochromocytoma 1 Perivascular Epithelioid Cell Neoplasms 1 Parathyroid Neoplasms 1 Paranasal Sinus Neoplasms 1 Paraganglioma 1 Paget Disease, Extramammary 1

Interventions

Bevacizumab 13 atezolizumab 12 Specimen Handling 9 Nivolumab 8 durvalumab 6 pembrolizumab 4 X-Rays 4 Radiosurgery 4 Magnetic Resonance Spectroscopy 4 Ipilimumab 4 lenvatinib 3 Sorafenib 3 Immunoglobulin G 3 E-7386 3 Cyclophosphamide 3 Blood Specimen Collection 3 sintilimab 2 regorafenib 2 cabozantinib 2 Disulfides 2 Biopsy 2 tremelimumab 1 tislelizumab 1 sofosbuvir-velpatasvir drug combination 1 sargramostim 1 sapanisertib 1 rocakinogene sifuplasmid 1 relatlimab 1 recombinant interferon alpha 2b-like protein 1 fludarabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡